PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 13, 2026International Journal of Cardiology Cardiovascular Risk and Prevention0 citationsOpen Access

Comment on “Renal and cardiovascular effects of SGLT2 inhibitors among hypertensive patients with chronic kidney disease: A systematic review and meta-analysis”

ZDZhenxing DengSWShaoxun Wen

Structured PICO

Do SGLT2 inhibitors improve renal and cardiovascular outcomes in hypertensive patients with chronic kidney disease?

P
Population
Hypertensive patients with chronic kidney disease
I
Intervention
SGLT2 inhibitors
O
Outcome
Renal and cardiovascular effects

This is a commentary on a systematic review and meta-analysis regarding the effects of SGLT2 inhibitors in hypertensive patients with chronic kidney disease.

Abstract

Comment on "Renal and cardiovascular effects of SGLT2 inhibitors among hypertensive patients with chronic kidney disease: A systematic review and meta-analysis"

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Deng et al. (2026) studied this question.

synapsesocial.com/papers/69dbd4b95b363cdf1c836055https://doi.org/10.1016/j.ijcrp.2026.200622
Ask AI
Helpful
Bookmark
Share
View Full Paper